Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |